Leonardo Secures 320M Deal to Equip Kuwaiti Patrol Vessels Expanding Gulf Presence JP Power Vodafone Idea and Easy Trip Planners Lead NSE Trading Activity on May 27 2026 Arafura Rare Earths to Raise A350 Million Backed by Hancock Prospecting for Nolans Project Myanmars Political Transition Requires Press Freedom Benchmarks CPJ Urges Intel Stock Decline Triggers Investor Scrutiny PubMatic PUBM Q1 2026 Earnings EPS Beats Estimates as AdTech Efficiency Drives Positive Surprise WEN Q1 2026 Earnings Profit Beat Lifts Shares Amid Cautious Consumer Outlook SM Energy Q1 2026 Earnings Strong EPS Beat Amid Market Headwinds MSI Q1 2026 Earnings EPS Beat Expectations on Solid Operational Execution Loews Corporation Q1 2026 Earnings EPS of 163 Driven by Diversified Portfolio Gesher Acquisition Corp II Warrants GSHRW Hold Steady at 022 Amid Low Volatility USGO Slides Over 2 as Gold Mining Stock Tests Key Support Zone 374Water Inc SCWO Shares Decline 679 Testing Key Support Levels OTGAW Warrants Hold Steady at 036 Amid Quiet Trading Support and Resistance Levels in Focus BOS Better Online Solutions BOSC Slips 32 as Shares Test Key Support Near 444 SBA Communications SBAC Slips to 20316 as Tower REIT Tests Key Support Zone EAEU Trade Turnover Surpasses 80 Billion as Leaders Pursue Deeper Integration CTOR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid No Reported Revenue El Nino Threatens Agricultural Output Across India and Australia WWEs Saturday Nights Main Event 2026 Potential Impact on TKO Groups Programming Strategy FFBC Q1 2026 Earnings EPS Surpasses Estimates by 8 Strengthening Investor Confidence Modular Medical Inc MODD Surges 458 as Stock Approaches Key Resistance Godzilla El Nio Threatens Crop Yields Across AsiaPacific Region Corn Futures Ease as Crude Oil Weakness Persists Super Micro Computer Stock Surges as AI Infrastructure Demand Intensifies Capital Ones Best Credit Card Offers for June 2026 What to Expect Dells Strong Quarter Sets Stage for AI Stock Week Ahead Jim Cramer Says Novartis Raises FullYear Sales and Profit Guidance Amid Strong Operational Performance Novo Nordisk Potential Undervaluation in Obesity Drug Leader